Thank you, Jay. I would like to remind you that our typical contract period is from June 1 to May 31 of the following year. Net premiums earned for the quarter ended June 30, 2023, were $183,000, slightly lower than the $194,000 in last year’s second quarter. For the first 6 months of 2023, net premiums were $183,000, down from $404,000 in the same period last year. The decrease is due to the number and size of reinsurance contracts in force during the period. There have been no losses to date incurred in 2023 or 2022. Our investment income and other income rose in the quarter and for 6 months of 2023 due to higher rates on money market funds. We generated $505,000 unrealized gain in the first half of 2023 due to a fair value change in our equity investment in Oxbridge Acquisition Corp. We also recognize $81,000 positive change in the fair value of our equity securities as of June 30, 2023, though much improved from the $342,000 negative change in the prior year. All of these factors taken together resulted in total revenue of $691,000 for the 3 months ended June 30, 2023, compared to $503,000 in the prior year second quarter. For the full 6 months of 2023, total revenue was $1.2 million compared to $505,000 for the same period last year. Total expenses included loss and loss adjustment expenses, policy acquisition costs and general and admin expenses were up in the second quarter and the first 6 months of 2023 compared to last year due primarily to inflation cost fluctuations, increased personnel costs as well as the recognition of all of the onetime offering costs related to strong profit in the second quarter. Primarily due to the onetime G&A offering costs in the second quarter, we generated a net loss of $85,000 or $0.01 per share compared to net income of $77,000 or $0.01 per share in the last year second quarter. For the 6 months ended June 30 year 2023, net profit was $57,000 compared to a net loss of $310,000 or $0.05 per share in the same period last year. The improvement this year was due to higher revenue driven by the increase in unrealized gains on investments, equity securities and management fee income from SurancePlus offering that more than offset the increase to one-time general and admin expenses associated with SurancePlus token offerings and the increased personnel costs. As we have discussed before on investor calls, we use various measures to analyze growth and profitability of our business operations. For reinsurance business, we measure underwriting profitability by combining our loss ratio, acquisition ratio, expense ratio and combined ratio. Our loss ratio, which measures underwriting profitability, is the ratio of loss and loss adjustment expenses incurred in net premiums earned. With new loss or loss adjustment expenses in either 2020 or 2022, the loss ratio was 0% for both periods. Our acquisition cost ratio, which measures operational efficiency, compares policy acquisition costs and net premiums earned. The acquisition ratio remained consistent with approximately 10.9% for the 3- and 6-month period ended June 2023 compared to the same period in the prior year. Our expense ratio, which measures operating performance, compares policy acquisition costs, and general and administrative expenses with net premiums earned. The expense ratio for the 3-month period ended June 30, 2023, increased from 211.3% at 380.9%. And for the 6 months ended June 30, 2023 from 191.1% to 601.6% when compared with prior periods. Increases were due to inflationary expense fluctuations, increased personnel costs as well as the recognition during the second quarter of 2023 of all of the onetime offering costs associated with the completion of the SurancePlus token offering. Our combined ratio, which is used to measure underwriting performance, is the sum of the loss ratio and expense ratio. The combined ratio for the 3-month period ended June 30, 2023, to 211.3% of 380.9% and for the 6 months ended June 30,2023, from 191.1% to 601.6%. When compared to the prior year period, again, the increases was due to inflationary expense fluctuations, increased personnel costs as well as recognition during the second quarter of the onetime offering costs associated with the completion of the SurancePlus token offering. [ Noting ] into the balance sheet, our investment portfolio increased 723 -- increased to $723,000 at June 30, 2023, from $642,000 prior year, largely due to gained experience so far this year. Other investment increased due to the positive change in the fair value for investment of Oxbridge Acquisition Corp. Cash and cash equivalents and restricted cash and cash equivalents decreased to $3.5 million at June 30, compared to $3.9 million at December 31, 2022. Total shareholders’ equity at quarter end increased to $15.1 million or $0.25 per common share. Now I’d like to turn the call back over to Jay to wrap up before we take your questions. Jay?